1. Home
  2. NINE vs GBIO Comparison

NINE vs GBIO Comparison

Compare NINE & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NINE
  • GBIO
  • Stock Information
  • Founded
  • NINE 2011
  • GBIO 2016
  • Country
  • NINE United States
  • GBIO United States
  • Employees
  • NINE N/A
  • GBIO N/A
  • Industry
  • NINE Oilfield Services/Equipment
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NINE Energy
  • GBIO Health Care
  • Exchange
  • NINE Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • NINE 30.7M
  • GBIO 29.2M
  • IPO Year
  • NINE 2018
  • GBIO 2020
  • Fundamental
  • Price
  • NINE $0.68
  • GBIO $0.36
  • Analyst Decision
  • NINE
  • GBIO Strong Buy
  • Analyst Count
  • NINE 0
  • GBIO 4
  • Target Price
  • NINE N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • NINE 694.5K
  • GBIO 507.0K
  • Earning Date
  • NINE 05-07-2025
  • GBIO 05-07-2025
  • Dividend Yield
  • NINE N/A
  • GBIO N/A
  • EPS Growth
  • NINE N/A
  • GBIO N/A
  • EPS
  • NINE N/A
  • GBIO N/A
  • Revenue
  • NINE $562,450,000.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • NINE $10.08
  • GBIO N/A
  • Revenue Next Year
  • NINE $2.01
  • GBIO $10.90
  • P/E Ratio
  • NINE N/A
  • GBIO N/A
  • Revenue Growth
  • NINE N/A
  • GBIO 146.47
  • 52 Week Low
  • NINE $0.60
  • GBIO $0.32
  • 52 Week High
  • NINE $2.07
  • GBIO $4.34
  • Technical
  • Relative Strength Index (RSI)
  • NINE 36.31
  • GBIO 39.03
  • Support Level
  • NINE $0.60
  • GBIO $0.36
  • Resistance Level
  • NINE $0.91
  • GBIO $0.41
  • Average True Range (ATR)
  • NINE 0.07
  • GBIO 0.04
  • MACD
  • NINE -0.00
  • GBIO -0.00
  • Stochastic Oscillator
  • NINE 25.00
  • GBIO 9.09

About NINE Nine Energy Service Inc.

Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: